Background: Metastatic uveal melanoma (mUM) is an aggressive malignancy with a dismal prognosis, posing a severe threat to patients' survival and quality of life. In recent years, tebentafusp, a novel immunotherapeutic agent, ha... ...

请注册登录后继续浏览